DIA Biosimilars 2013

Phase Forward

Phase Forward Beats Sales, Profit Guidance and Stock Soars 30%

Wednesday, April 29, 2009 09:40 AM

Waltham, Mass.-based eClinical company Phase Forward reported first quarter revenues jumped 28% to $48.8 million, compared with the first quarter of 2008.

More... »

Cenduit: Now with Patient Reminders

Global Acquisitions Heat Up

Monday, April 27, 2009 08:00 AM

Three companies—Phase Forward, Chiltern International and ChemDiv—are the latest clinical trial companies to complete global acquisitions.

More... »

CRF Health – eCOA Forum

Phase Forward Acquires Waban Software

Thursday, April 23, 2009 07:12 AM

Phase Forward, an eClinical company, acquired Waban Software, a Cambridge, Mass.-based clinical data analysis and reporting company with operations in Mumbai, India, for $14 million in cash.

More... »

Phase Forward Revenues Up 27%, CFO to Retire

Friday, February 6, 2009 10:13 AM

Waltham, Mass.-based eClinical technology company Phase Forward reported a strong fourth quarter and year end 2008, posting a 27% increase in revenues for the year and a 28% increase in revenues in Q4 compared with  the same period last year.

More... »

Phase Forward Revenues Up 23%

Wednesday, October 29, 2008 09:22 AM

Waltham, Mass.-based eClinical technology company Phase Forward reported a 23% jump in third quarter revenues to $43 million from $34.9 million in the third quarter of 2007.

More... »

Phase Forward Founder Steps Down

Thursday, October 9, 2008 01:00 PM

Dr. Paul Bleicher, chairman and founder of Waltham, Mass.-based eClinical technology company Phase Forward, will step down from his day-to-day operational responsibilities at the end of October. Phase Forward president and CEO Robert Weiler will also assume Bleicher’s role as chairman of the company’s board of directors, of which Bleicher will remain a member.

More... »

Phase Forward Acquires IRT Provider Clarix

Monday, September 8, 2008 01:00 PM

Waltham, Mass.-based eClinical technology company Phase Forward has acquired Clarix, a privately held provider of Web-integrated interactive response technology (IRT) based in Radnor, Pa., for $40 million in cash.

More... »

Phase Forward Revenue Jumps 30%

Wednesday, July 30, 2008 09:07 AM

Waltham, Mass.-based Phase Forward, a provider of data management solutions for clinical trials and drug safety, reported after the bell Monday a 30% jump in second quarter revenues to $40.9 million from $31.5 million in the second quarter of 2007.

More... »

CWWeekly June 30th 2008 Issue

Monday, July 7, 2008 10:32 AM

Top News

More... »

eClinical Round-Up

Tuesday, July 1, 2008 09:47 AM

During the DIA 2008 Annual Meeting held in Boston, Phase Forward announced it formed an alliance with AG Mednet to streamline the process of transporting medical imaging, such as MRIs, CAT scans and ultrasounds. The alliance calls for the combining of InForm, Phase Forward’s trial management system, and AG Mednet’s imaging transport network for better tracking and management of patient images in real time from sites to imaging experts. “Clinical trial sponsors need a way to transport patient images more quickly and efficiently for less cost, and a real-time capability to track and manage these images,” said Martin Young Phase Forward’s vice president of corporate development and marketing.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs